High-resolution Quantification of Specific MRNA Levels in Human Brain Autopsies and Biopsies

Overview

Journal Genome Res

Specialty Genetics

Date 2000 Aug 25

PMID 10958640

Citations 22

Authors

A Castensson

L Emilsson

P Preece

E E Jazin

Affiliations

Soon will be listed here.

Abstract

Quantification of mRNA levels in human cortical brain biopsies and autopsies was performed using a fluorogenic 5' nuclease assay. The reproducibility of the assay using replica plates was 97%-99%. Relative quantities of mRNA from 16 different genes were evaluated using a statistical approach based on ANCOVA analysis. Comparison of the relative mRNA levels between two groups of samples with different time postmortem revealed unchanged relative expression levels for most genes. Only CYP26A1 mRNA levels showed a significant decrease with prolonged time postmortem (p = 0.00004). Also, there was a general decrease in measured mRNA levels for all genes in autopsies compared to biopsies; however, on comparing mRNA levels after adjusting with reference genes, no significant differences were found between mRNA levels in autopsies and biopsies. This observation indicates that studies of postmortem material can be performed to reveal the relative in vivo mRNA levels of genes. Power calculations were done to determine the number of individuals necessary to detect differences in mRNA levels of 1.5-fold to tenfold using the strategy described here. This analysis showed that samples from at least 50 individuals per group, patients and controls, are required for high-resolution ( approximately twofold changes) differential expression screenings in the human brain. Experiments done on ten individuals per group will result in a resolution of approximately fivefold changes in expression levels. In general, the sensitivity and resolution of any differential expression study will depend on the sample size used and the between-individual variability of the genes analyzed.

Citing Articles

An analysis of RNA quality metrics in human brain tissue.

Tian J, Lam T, Ross S, Ciener B, Leskinen S, Sivakumar S J Neuropathol Exp Neurol. 2024; 84(3):236-243.

PMID: 39715490 PMC: 11842900. DOI: 10.1093/jnen/nlae132.

Using Postmortem hippocampi tissue can interfere with differential gene expression analysis of the epileptogenic process.

Born J, Matos H, de Araujo M, Castro O, Duzzioni M, Peixoto-Santos J PLoS One. 2017; 12(8):e0182765.

PMID: 28783762 PMC: 5544225. DOI: 10.1371/journal.pone.0182765.

Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.

Farnsworth B, Peuckert C, Zimmermann B, Jazin E, Kettunen P, Emilsson L J Alzheimers Dis. 2016; 53(1):209-19.

PMID: 27163826 PMC: 4942724. DOI: 10.3233/JAD-160160.

A standardized autopsy procurement allows for the comprehensive study of DIPG biology.

Kambhampati M, Perez J, Yadavilli S, Saratsis A, Hill A, Ho C Oncotarget. 2015; 6(14):12740-7.

PMID: 25749048 PMC: 4494970. DOI: 10.18632/oncotarget.3374.

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Beach T, Adler C, Sue L, Serrano G, Shill H, Walker D Neuropathology. 2015; 35(4):354-89.

PMID: 25619230 PMC: 4593391. DOI: 10.1111/neup.12189.

References

Juchau M . Expression of cytochrome P450RAI (CYP26) in human fetal hepatic and cephalic tissues. Biochem Biophys Res Commun. 1998; 252(2):487-91. DOI: 10.1006/bbrc.1998.9659. View

Gaddis M . Statistical methodology: IV. Analysis of variance, analysis of covariance, and multivariate analysis of variance. Acad Emerg Med. 1998; 5(3):258-65. DOI: 10.1111/j.1553-2712.1998.tb02624.x. View

Lieberman J, Mailman R, Duncan G, Sikich L, Chakos M, Nichols D . Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry. 1998; 44(11):1099-117. DOI: 10.1016/s0006-3223(98)00187-5. View

Terzano S, Court J, Fornasari D, Griffiths M, Spurden D, Lloyd S . Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. Brain Res Mol Brain Res. 1998; 63(1):72-8. DOI: 10.1016/s0169-328x(98)00260-5. View

Eisen M, Spellman P, Brown P, Botstein D . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998; 95(25):14863-8. PMC: 24541. DOI: 10.1073/pnas.95.25.14863. View

Harrison P, Eastwood S . Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet. 1998; 352(9141):1669-73. DOI: 10.1016/S0140-6736(98)03341-8. View

Stoffel-Wagner B, Watzka M, Steckelbroeck S, Schramm J, Bidlingmaier J, Klingmuller D . Expression of 17beta-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe. J Endocrinol. 1998; 160(1):119-26. DOI: 10.1677/joe.0.1600119. View

Leboyer M, Bellivier F, Nosten-Bertrand M, Jouvent R, Pauls D, Mallet J . Psychiatric genetics: search for phenotypes. Trends Neurosci. 1998; 21(3):102-5. DOI: 10.1016/s0166-2236(97)01187-9. View

Heffernan J, Eastwood S, Nagy Z, Sanders M, McDonald B, Harrison P . Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia. Exp Neurol. 1998; 150(2):235-9. DOI: 10.1006/exnr.1997.6772. View

10.

Stoffel-Wagner B, Watzka M, Steckelbroeck S, Schwaab R, Schramm J, Bidlingmaier F . Expression of CYP19 (aromatase) mRNA in the human temporal lobe. Biochem Biophys Res Commun. 1998; 244(3):768-71. DOI: 10.1006/bbrc.1998.8337. View

11.

McFadyen M, Melvin W, Murray G . Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem Pharmacol. 1998; 55(6):825-30. DOI: 10.1016/s0006-2952(97)00516-9. View

12.

Ohnuma T, Augood S, Arai H, McKenna P, Emson P . Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res Mol Brain Res. 1998; 56(1-2):207-17. DOI: 10.1016/s0169-328x(98)00063-1. View

13.

Mitsuyama H, Little K, Sieghart W, Devaud L, Morrow A . GABA(A) receptor alpha1, alpha4, and beta3 subunit mRNA and protein expression in the frontal cortex of human alcoholics. Alcohol Clin Exp Res. 1998; 22(4):815-22. View

14.

Benisty S, Boissiere F, Faucheux B, Agid Y, Hirsch E . trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study. Neuroscience. 1998; 86(3):813-26. DOI: 10.1016/s0306-4522(98)00126-2. View

15.

Pasinetti G, Aisen P . Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience. 1998; 87(2):319-24. DOI: 10.1016/s0306-4522(98)00218-8. View

16.

HRDINA P, Faludi G, Li Q, Bendotti C, Tekes K, Sotonyi P . Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides. Mol Psychiatry. 1998; 3(5):411-8. DOI: 10.1038/sj.mp.4000435. View

17.

Marton M, DeRisi J, Bennett H, Iyer V, Meyer M, Roberts C . Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med. 1998; 4(11):1293-301. DOI: 10.1038/3282. View

18.

Myers L, Gustafsson C, Hayashibara K, Brown P, Kornberg R . Mediator protein mutations that selectively abolish activated transcription. Proc Natl Acad Sci U S A. 1999; 96(1):67-72. PMC: 15094. DOI: 10.1073/pnas.96.1.67. View

19.

Eastwood S, Harrison P . Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience. 1999; 86(2):437-48. DOI: 10.1016/s0306-4522(98)00040-2. View

20.

Iyer V, Eisen M, Ross D, Schuler G, Moore T, Lee J . The transcriptional program in the response of human fibroblasts to serum. Science. 1999; 283(5398):83-7. DOI: 10.1126/science.283.5398.83. View